REMEDY : BNSSG referral pathways & Joint Formulary


Home > BNSSG ICB > Development Area > Neurosurgery - DRAFT >

Skull base tumours DRAFT

Checked: not set yet by Jenny Henry Next Review: not set yet

If a patient with recent imaging evidence of a skull base tumour acutely presents with severe headaches, progressive neurological decline or a rapidly progressive cranial nerve palsy (over the course of days), please refer urgently to our on-call via Refer-a-Patient.
Otherwise please refer via skull base MDT.

most skullbase tumours are benign, and don’t fit the criteria on the 2ww form

( New and / or progressive neurological deficit, with or without cranial nerve palsies (please note that deafness alone cannot be defined as a neurological deficit)

Headaches with other features of raised intracranial pressure (ICP), such as headache worse on waking, associated with vomiting, with or without papilloedema

Previous history of cancer with unresolved headaches)

The skullbase MDT link is also on that Remedy page however, so it’s the same information



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.